Neuronal K+-Cl- cotransporter KCC2 as a promising drug target for epilepsy treatment

E McMoneagle, J Zhou, S Zhang, W Huang… - Acta Pharmacologica …, 2024 - nature.com
Epilepsy is a prevalent neurological disorder characterized by unprovoked seizures. γ-
Aminobutyric acid (GABA) serves as the primary fast inhibitory neurotransmitter in the brain …

Role of NKCC1 and KCC2 in epilepsy: from expression to function

R Liu, J Wang, S Liang, G Zhang, X Yang - Frontiers in neurology, 2020 - frontiersin.org
As a main inhibitory neurotransmitter in the central nervous system, γ-aminobutyric acid
(GABA) activates chloride-permeable GABAa receptors (GABAa Rs) and induces chloride …

Noninvasive targeted transcranial neuromodulation via focused ultrasound gated drug release from nanoemulsions

RD Airan, RA Meyer, NPK Ellens, KR Rhodes… - Nano …, 2017 - ACS Publications
Targeted, noninvasive neuromodulation of the brain of an otherwise awake subject could
revolutionize both basic and clinical neuroscience. Toward this goal, we have developed …

Brain-derived neurotrophic factor and epilepsy: a systematic review

L Iughetti, L Lucaccioni, F Fugetto, B Predieri, A Berardi… - Neuropeptides, 2018 - Elsevier
Several in vitro, ex vivo and in vivo studies imply brain-derived neurotrophic factor (BDNF) in
the pathophysiology of epilepsy. Aim of our work is to report the most important findings …

[HTML][HTML] Synaptic genes and neurodevelopmental disorders: From molecular mechanisms to developmental strategies of behavioral testing

C Michetti, A Falace, F Benfenati, A Fassio - Neurobiology of Disease, 2022 - Elsevier
Synaptopathies are a class of neurodevelopmental disorders caused by modification in
genes coding for synaptic proteins. These proteins oversee the process of …

Excitatory/inhibitory balance in epilepsies and neurodevelopmental disorders: Depolarizing γ‐aminobutyric acid as a common mechanism

EJH van van Hugte, D Schubert, N Nadif Kasri - Epilepsia, 2023 - Wiley Online Library
Epilepsy is one of the most common neurological disorders. Although many factors
contribute to epileptogenesis, seizure generation is mostly linked to hyperexcitability due to …

Neonatal seizures: impact on neurodevelopmental outcomes

SK Kang, SD Kadam - frontiers in Pediatrics, 2015 - frontiersin.org
Neonatal period is the most vulnerable time for the occurrence of seizures, and neonatal
seizures often pose a clinical challenge both for their acute management and frequency of …

[HTML][HTML] Novel therapeutics for neonatal seizures

JM Ziobro, K Eschbach, RA Shellhaas - Neurotherapeutics, 2021 - Elsevier
Neonatal seizures are a common neurologic emergency for which therapies have not
significantly changed in decades. Improvements in diagnosis and pathophysiologic …

Dose-dependent reversal of KCC2 hypofunction and phenobarbital-resistant neonatal seizures by ANA12

BM Carter, BJ Sullivan, JR Landers, SD Kadam - Scientific Reports, 2018 - nature.com
Neonatal seizures have an incidence of 3.5 per 1000 newborns; while hypoxic-ischemic
encephalopathy (HIE) accounts for 50–60% of cases, half are resistant to 1st-line anti …

Targeting ischemia-induced KCC2 hypofunction rescues refractory neonatal seizures and mitigates epileptogenesis in a mouse model

BJ Sullivan, PA Kipnis, BM Carter, LR Shao… - Science …, 2021 - science.org
Neonatal seizures pose a clinical challenge in their early detection, acute management, and
long-term comorbidities. They are often caused by hypoxic-ischemic encephalopathy and …